Utah Medical Products, Inc. (UTMD)

Utah Medical Products Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	84.27	82.98	92.87	75.05	60.97	51.59
Cash & Short-Term Investments	84.27	82.98	92.87	75.05	60.97	51.59
Cash Growth	-4.73%	-10.65%	23.74%	23.09%	18.19%	20.57%
Accounts Receivable	3.73	4.1	3.34	5.54	5.13	4.09
Other Receivables	-	-0	0.05	-	-	0.01
Receivables	3.73	4.09	3.39	5.54	5.13	4.1
Inventory	8.12	8.81	9.58	8.81	6.6	6.22
Prepaid Expenses	-	0.45	0.43	0.52	0.46	0.35
Total Current Assets	96.53	96.33	106.27	89.92	73.16	62.26
Property, Plant & Equipment	10	9.76	10.55	10.22	10.62	11.33
Goodwill	-	13.58	13.69	13.35	14.1	14.16
Other Intangible Assets	15.44	2.87	4.95	10.38	17.76	23.99
Total Assets	121.98	122.54	135.46	123.87	115.64	111.75
Accounts Payable	0.77	0.7	0.77	1.22	0.76	0.79
Accrued Expenses	2.24	3.05	3.36	4.2	2.85	2.89
Current Portion of Leases	-	0.06	-	-	-	-
Current Income Taxes Payable	-	-0.15	0.33	0.34	0.04	0
Other Current Liabilities	-	0.11	0.26	0.2	0.1	0.11
Total Current Liabilities	3.01	3.76	4.71	5.96	3.75	3.79
Long-Term Leases	0.24	0.28	0.3	0.34	0.4	0.34
Long-Term Deferred Tax Liabilities	0.25	1.07	1.44	2.06	2.68	2.8
Other Long-Term Liabilities	-	-	0.7	1.26	1.68	2
Total Liabilities	3.72	5.11	7.15	9.62	8.5	8.92
Common Stock	118.25	0.03	0.04	0.04	0.04	0.04
Additional Paid-In Capital	-	-	0.59	0.25	0.84	0.12
Retained Earnings	-	129.3	138.34	126.01	115.31	110.95
Comprehensive Income & Other	-	-11.91	-10.66	-12.04	-9.05	-8.28
Shareholders' Equity	118.25	117.43	128.31	114.25	107.14	102.82
Total Liabilities & Equity	121.98	122.54	135.46	123.87	115.64	111.75
Total Debt	0.24	0.34	0.3	0.34	0.4	0.34
Net Cash (Debt)	84.03	82.64	92.57	74.71	60.58	51.26
Net Cash Growth	-4.68%	-10.73%	23.91%	23.33%	18.19%	20.85%
Net Cash Per Share	25.56	23.59	25.45	20.51	16.55	13.96
Filing Date Shares Outstanding	3.2	3.28	3.59	3.63	3.65	3.65
Total Common Shares Outstanding	3.2	3.34	3.63	3.63	3.66	3.64
Working Capital	93.52	92.57	101.56	83.96	69.41	58.47
Book Value Per Share	36.91	35.21	35.35	31.49	29.31	28.22
Tangible Book Value	102.81	100.98	109.68	90.52	75.28	64.67
Tangible Book Value Per Share	32.09	30.28	30.22	24.95	20.60	17.75
Land	-	1.6	1.64	1.59	1.69	1.73
Buildings	-	13.54	13.91	13.6	14.17	14.53
Machinery	-	18.53	17.32	17.07	16.66	16.75
Construction In Progress	-	0.02	1.41	0.91	0.9	0.53
Order Backlog	-	1.89	3.65	5.61	4.96	3.01

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q